Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide was discovered through research into dual agonists that target both GIP and GLP-1 receptors, with the goal of improving glucose control and weight loss in patients with diabetes and obesity
FOXO4-DRI targets senescent cells, which contribute to inflammation and fibrosis, by inducing their apoptosis, thereby reducing lung damage
Glucagon receptor signaling Glucagon is secreted by pancreatic alpha cells and serves as a major counter-regulatory hormone to insulin
Additionally, those with type 2 diabetes can benefit from the dual-action of weight loss and improved blood sugar management
US$ 28.42
US$ 27.01
US$ 20.89
US$ 27.14
US$ 23.01
US$ 20.06
